Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Combined pituitary hormone deficiency represents a disorder with complex etiology. For many patients, causes of the disease remain unexplained, despite usage of advanced genetic testing. Although major and common transcription factors were identified two decades ago, we still struggle with identification of rare inborn factors contributing to pituitary function. In this report, we follow up genomic screening of
CPHD
patient cohort that were previously tested for changes in a coding sequences of genes with the use of the whole exome. We aimed to find contribution of rare copy number variations (CNVs). As a result, we identified genomic imbalances in 7 regions among 12
CPHD
patients. Five out of seven regions showed copy gains whereas two presented losses of genomic fragment. Three regions with detected gains encompassed known
CPHD
genes namely
LHX4, HESX1
, and
OTX2
. Among new
CPHD
loci, the most interesting seem to be the region covering
SIX3
gene, that is abundantly expressed in developing brain, and together with
HESX1
contributes to pituitary organogenesis as it was evidenced before in functional studies. In conclusion, with the use of broadened genomic approach we identified copy number imbalances for 12
CPHD
patients. Although further functional studies are required in order to estimate its true impact on expression pattern during pituitary organogenesis and
CPHD
etiology.
Int J
Mol
Sci 2020 Aug 11
PMID:Copy Number Variants Contributing to Combined Pituitary Hormone Deficiency. 3279 91